Oracle is behind the AI demand curve, but this could spell accelerating growth and significant upside for investors.
Oracle's stock has plummeted since hitting a high of $345 in September 2025. Will a record quarter quell fears?
Oracle Corporation (NYSE:ORCL) Q3 2026 Earnings Call Transcript March 10, 2026 Oracle Corporation beats earnings expectations. Reported EPS is $1.79, expectations were $1.7. Operator: Hello, and thank ...
Oracle Corporation is rated a Buy due to robust execution, margin inflection, and high potential cloud growth opportunity.
Oracle (ORCL) closed at $141.31 in the latest trading session, marking a -4.57% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 1.04%. Meanwhile, the Dow lost 1 ...
Oracle is making its Health Clinical AI Agent available to NHS trust and private practices. The note-taking software has been piloted at a number of hospital trusts in the UK, including Barts Health ...
LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new ...
To finance its artificial-intelligence ambitions, Oracle is looking to raise more money at a time when Wall Street has gotten more worried about the level of financing underpinning the AI boom. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results